Imperagen is a biotechnology company specialising in closed-loop, AI-guided enzyme engineering. It combines quantum and physics-based modelling, automated laboratory testing and experimental feedback to design, build and optimise enzyme variants more quickly and predictably than traditional screening methods. Its services support enzyme improvement for activity, selectivity, stability, yield, manufacturability, scalability and process cost. Imperagen works with organisations in chemical manufacturing, biopharma, molecular biology, consumer products and industrial biotechnology, helping them develop production-ready biocatalysts for greener synthesis, improved manufacturing efficiency, sustainable processes and advanced therapeutic or industrial applications.